SciELO - Scientific Electronic Library Online

vol.71 issue9BViral encephalitisMansonic neuroschistosomiasis author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links


Arquivos de Neuro-Psiquiatria

Print version ISSN 0004-282XOn-line version ISSN 1678-4227


TAKAYANAGUI, Osvaldo M.. Neurocysticercosis. Arq. Neuro-Psiquiatr. [online]. 2013, vol.71, n.9B, pp.710-713. ISSN 0004-282X.

Cysticercosis is one of the most common parasitic diseases of the nervous system in humans, and constitutes a major public health problem for most of the developing world. The clinical manifestations of neurocysticercosis (NCC) largely depend on the the host immune response against the parasite. NCC diagnosis is based upon neuroimaging studies (computerized tomography, magnetic resonance imaging) and antibody/antigen detection in the serum and the cerebrospinal fluid. Anticysticercal therapy has been marked by an intense controversy. Randomized controlled trials evaluating the clinical benefit of treatment have yield conflicting data with some studies indicating a benefit and others failing to show a difference. Prevention strategies must rely on multiple approaches, tailoring each to the special features of the particular endemic area.

Keywords : cysticercosis; Taenia solium; epilepsy; albendazole; praziquantel; cisticercose; Taenia solium; epilepsia; albendazol; praziquantel.

        · abstract in Portuguese     · text in English     · English ( pdf )